A Pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma

Cancer

Volumn 98, Issue 2, 2003, Pages 277-282

  Jones, Ellen L ^a   Samulski, Thaddeus V ^a   Dewhirst, Mark W ^a   Alvarez Secord, Angeles ^a   Berchuck, Andrew ^a   Clarke Pearson, Daniel ^a   Havrilesky, Laura J ^a   Soper, John ^a   Prosnitz, Leonard R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cervical carcinoma; Cisplatin; Hyperthermia; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; HYPERTHERMIC THERAPY; HYSTERECTOMY; LUNG METASTASIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PARAAORTIC LYMPH NODE; PELVIS; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0038340437     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11475     Document Type: Article

References (26)

1. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky Stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
2. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340:1137-1143.
3. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
4. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
5. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
6. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781-786.
7. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000; 355:1119-1125.
8. Bornstein BA, Herman TS, Hansen JL, et al. Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours. Int J Hyperthermia. 1995;11:489-499.
9. Herman TS, Jochelson MS, Teicher BA, et al. A Phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys. 1989;17:1273-1279.
10. Serin M, Erkal HS, Cakmak A. Radiation therapy, cisplatin and hyperthermia in combination in management of patients with carcinomas of the head and neck with N2 or N3 metastatic cervical lymph nodes. Radiother Oncol. 1999;50: 103-106.
11. Sapozink MD, Corry PM, Kapp DS, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia for deep-seated malignancy. Int J Radiat Oncol Biol Phys. 1991;20:1109-1115.
12. Dinges S, Harder C, Wurm R, et al. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a Phase II trial. Strahlenther Onkol. 1998;174:517-521.
13. Hornback NB, Shupe RE, Shidnia H, Marshall CU, Lauer T. Advanced Stage IIIB cancer of the cervix treatment by hyperthermia and radiation. Gynecol Oncol. 1986;23:160-167.
14. Sharma S, Singhal S, Sandhu AP, Ghoshal S, Gupta BD, Yadav NS. Local thermo-radiotherapy in carcinoma cervix: improved local control versus increased incidence of distant metastasis. Asia Oceania J Obstet Gynaecol. 1991; 17:5-12.
15. Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in Stage IIIB cervical carcinoma. Int J Hyperthermia. 2001;17:97-105.
16. Herman TS, Teicher BA, Cathcart KN, Kaufmann ME, Lee JB, Lee MH. Effect of hyperthermia on cis-diamminedichloro-platinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Cancer Res. 1988;48:5101-5105.
17. Schem BC, Mella O, Dahl O. Thermochemotherapy with cisplatin or carboplatin in the BT4 rat glioma in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1992;23:109-114.
18. Urano M, Kahn J, Majima H, Gerweck LE. The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int J Hyperthermia. 1990;6:581-590.
19. Alberts DS, Peng YM, Chen HS, Moon TE, Cetas TC, Hoeschele JD. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J Natl Cancer Inst. 1980;65: 455-461.
20. Ohno S, Siddik ZH, Kido Y, Zwelling LA, Bull JM. Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol. 1994;34:302-306.
21. Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation. Int J Hyperthermia. 1991;7:773-784.
22. Meyn RE, Corry PM, Fletcher SE, Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res. 1980; 40:1136-1139.
23. Raaphorst GP, Chabot P, Doja S, Wilkins D, Stewart D, Ng CE. Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. Int J Hyperthermia. 1996;12:211-222.
24. Masuda H, Tanaka T, Matsushima S. Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system. Anticancer Res. 1998;18:1473-1477.
25. Raaphorst GP, Miao J, Stewart D, Ng CE. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells. Cancer Chemother Pharmacol. 1998;41:491-496.
26. Raaphorst GP, Maio J, Ng CE, Stewart DJ. Concomitant treatment with mild hyperthermia, cisplatin and low doserate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin. Oncol Rep. 1998;5:971-977.